Clinical implications of recurrent gene mutations in acute myeloid leukemia
Abstract Acute myeloid leukemia (AML) is a genetically heterogeneous clonal malignancy characterized by recurrent gene mutations. Genomic heterogeneity, patients’ individual variability, and recurrent gene mutations are the major obstacles among many factors that impact treatment efficacy of the AML...
Tallennettuna:
| Päätekijät: | , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BMC
2020-03-01
|
| Sarja: | Experimental Hematology & Oncology |
| Aiheet: | |
| Linkit: | http://link.springer.com/article/10.1186/s40164-020-00161-7 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|